Clincosm LogoSign in Get a demo

hepatitis

Showing 26 - 50 of 90
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cirrhosis, Hepatitis Trial in Seoul (Liver MRI)

Active, not recruiting
  • Cirrhosis
  • Hepatitis
  • Liver MRI
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Oct 18, 2020

Hepatitis Trial in Kaohsiung City, Kaohsiung (Pioglitazone, )

Completed
  • Hepatitis
  • Kaohsiung City, Taiwan
  • +1 more
Jul 22, 2020

Hepatitis Trial in Assiut (Systolic function by echocardiography, Diastolic function by echocardiography)

Unknown status
  • Hepatitis
  • Systolic function by echocardiography
  • Diastolic function by echocardiography
  • Assiut, Egypt
    Faculty of Medicine
Jan 21, 2020

Hypertension, Arthritis, Coronary Artery Disease Trial in Atlanta (HARP Intervention)

Completed
Has Results
  • Hypertension
  • +7 more
  • HARP Intervention
  • Atlanta, Georgia
    Central Fulton Community Mental Health Center at Grady Hospital
Sep 20, 2019

Arthritis, Systemic Lupus Erythematosus, Rheumatoid Arthritis Trial in Paris, Strasbourg (drug inducing arthritis, lupus,

Completed
  • Arthritis
  • +4 more
  • drug inducing arthritis, lupus, hepatitis, or capillary leak syndrom
  • Paris, France
  • +1 more
Sep 2, 2019

Hepatitis, Hepatitis C, Digestive System Diseases Trial (MK-3682B, Ribavirin)

Terminated
Has Results
  • Hepatitis
  • +7 more
  • (no location specified)
Jul 15, 2019

Ascites, Blunt Abdominal Trauma, Cholelithiasis Trial in Punta Cana (SonoSite Titan portable ultrasound coupled with email

Completed
  • Ascites
  • +13 more
  • SonoSite Titan portable ultrasound coupled with email telediagnosis
  • Punta Cana, La Altagracia, Dominican Republic
    Primary Clinic of Veron
Jul 18, 2019

Hepatitis Trial in Kathmandu (Hepatitis E vaccine, recombinant (Sar 56 kDa), Placebo)

Completed
Has Results
  • Hepatitis
  • Hepatitis E vaccine, recombinant (Sar 56 kDa)
  • Placebo
  • Kathmandu, Nepal
    Shree Birendra Hospital
May 8, 2019

Hepatitis C, Chronic, Liver Diseases, Hepatitis Trial in Novosibirsk (Autologous DC-vaccines)

Completed
Has Results
  • Hepatitis C, Chronic
  • +3 more
  • Autologous DC-vaccines
  • Novosibirsk, Russian Federation
    Institute of Fundamental and Clinical Immunology
Feb 6, 2019

Protein Biomarker in Hepatocellular Carcinoma

Terminated
  • Normal Volunteers
  • +3 more
    • Singapore, Singapore
      Johns Hopkins Singapore International Medical Center
    Feb 12, 2019

    Hepatitis Trial (Data Collection)

    Completed
    Has Results
    • Hepatitis
    • Data Collection
    • (no location specified)
    Sep 7, 2018

    Hepatitis, Hepatitis C, Hepatitis C/ Human Immunodeficiency Virus Coinfection Trial in Russian Federation (Algeron, PegIntron)

    Completed
    Has Results
    • Hepatitis
    • +2 more
    • Kazan, Republic Of Tatarstan, Russian Federation
    • +5 more
    Jul 13, 2018

    Hepatitis, Hepatitis C Trial in Worldwide (Algeron, Pegasys)

    Completed
    • Hepatitis
    • Hepatitis C
    • Gomel, Belarus
    • +18 more
    Jul 13, 2018

    Hepatitis, Hepatitis B, Hepatitis C Trial in Guangzhou (Crowdsourced materials, Control)

    Completed
    • Hepatitis
    • +2 more
    • Crowdsourced materials
    • Control
    • Guangzhou, China
      UNC Project-China
    Jun 18, 2018

    HIV-1 Infection, Hepatitis Trial in United States (Sofosbuvir, Ribavirin, Ledipasvir/Sofosbuvir)

    Completed
    Has Results
    • HIV-1 Infection
    • Hepatitis
    • San Diego, California
    • +11 more
    Mar 29, 2018

    Hepatitis Trial (entecavir+resveratrol, Entecavir, entecavir+thymosin a1)

    Completed
    • Hepatitis
    • (no location specified)
    Apr 25, 2018

    Fatty Liver, Hepatitis Trial run by the NIAID (Diagnostic Radiology: 1H-MRS of the liver)

    Completed
    • Fatty Liver
    • Hepatitis
    • Diagnostic Radiology: 1H-MRS of the liver
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jun 30, 2017

    Trends Over Time of Hepatitis Related Incidence in Panama

    Completed
    • Hepatitis
    • Epidemiologic Surveillance System of the Ministry of Health of Panama
    • Clayton, Panamá, Panama
      GSK Investigational Site
    Jun 6, 2017

    Hepatitis, Hepatitis C, Chronic, Fibrosis Trial (PegIntron (peginterferon alfa-2b; SCH 54031), REBETOL (ribavirin; SCH 18908))

    Completed
    Has Results
    • Hepatitis
    • +3 more
    • PegIntron (peginterferon alfa-2b; SCH 54031)
    • REBETOL (ribavirin; SCH 18908)
    • (no location specified)
    Mar 7, 2017

    Empowering Immigrants in Greater Boston Area to Connect to HBV

    Unknown status
    • Hepatitis
      • (no location specified)
      Mar 26, 2017

      Utilization of Antiviral Therapies in Hepatitis C and

      Completed
      • Hepatitis
        • Hamburg, Germany
          Local Institution
        Mar 3, 2017

        Hepatitis Trial in ChungNam (Tenofovir disoproxil)

        Completed
        • Hepatitis
        • Tenofovir disoproxil
        • ChungNam, Korea, Republic of
          ChungNam university hospital
        Jan 25, 2017

        Substance-Related Disorders, Hepatitis Trial in Seattle (Pegylated Interferon)

        Completed
        • Substance-Related Disorders
        • Hepatitis
        • Pegylated Interferon
        • Seattle, Washington
          Harborview Medical Center, 325 Ninth Ave 1EC32
        Jan 11, 2017

        HBV (Hepatitis B Virus), Hepatitis B, Hepatitis Trial run by the NIDDK (Lamivudine and adefovir, Adefovir alone)

        Completed
        Has Results
        • HBV (Hepatitis B Virus)
        • +2 more
        • Lamivudine and adefovir
        • Adefovir alone
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Sep 22, 2016

        Hepatitis, Hepatitis B, Liver Diseases Trial in Maoming, Yunfu (10µg/0.5ml recombinant hepatitis B vaccine)

        Unknown status
        • Hepatitis
        • +3 more
        • 10μg/0.5ml recombinant hepatitis B vaccine
        • Maoming, Guangdong, China
        • +1 more
        May 5, 2016